Merck (MRK) Accumulated Expenses (2009 - 2011)

Merck (MRK) has reported Accumulated Expenses for 3 consecutive years, with $8.6 billion the latest figure, recorded in Q1 2011.

• In Q1 2011, Accumulated Expenses rose 1.37% year-over-year to $8.6 billion; the TTM figure through Mar 2011 stood at $8.6 billion (up 1.37% YoY), while the FY2010 annual figure was $8.5 billion, down 9.95% from the prior year.
• Accumulated Expenses held at $8.6 billion in Q1 2011 per MRK's latest filing, from $8.5 billion in the prior quarter.
• Across five years, Accumulated Expenses topped out at $9.5 billion in Q4 2009 and bottomed at $828.0 million in Q2 2009.
• Historically, Accumulated Expenses has averaged $6.5 billion across 3 years, with a median of $8.3 billion in 2010.
• On a YoY basis, Accumulated Expenses climbed as much as 743.8% in 2010 and fell as far as 9.95% in 2010.
• Merck's Accumulated Expenses stood at $9.5 billion in 2009, then fell by 9.95% to $8.5 billion in 2010, then climbed by 0.48% to $8.6 billion in 2011.
• Business Quant data shows MRK's Accumulated Expenses at $8.6 billion in Q1 2011, $8.5 billion in Q4 2010, and $8.2 billion in Q3 2010.